Email - Positive Alzheimer's treatment data brings hope and enthusiasm

Donate

Enews from the Alzheimer's Association

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.

24/7 Helpline: 800.272.3900

Positive Alzheimer's treatment data brings hope and enthusiasm

Positive results of the drug lecanemab were recently reported in Alzheimer's clinical trials, giving those facing the disease hope for more effective treatments. On our blog, Alzheimer’s Association Chief Science Officer Maria C. Carrillo, Ph.D., says that while lecanemab is not yet in doctors’ offices, this development is history in the making: “This is the time we will look back at and say, ‘That was when it all started.’”

Make 2X the impact during our Autumn $100,000 2X Match Challenge

Show your support during this match challenge while you can double your impact in the fight to end Alzheimer's. Your gift before Oct. 11 can go 2X as far, up to $100,000, to accelerate research and help provide care and support to those facing the disease.

Help fight Alzheimer's

Give Now

Get Involved

Your Local Community

Find a chapter here

Shop to help fight Alzheimer's during Amazon’s Prime Early Access Sale

Amazon’s Prime Early Access Sale is Oct. 11-12. Amazon Prime members can support the fight against Alzheimer’s by shopping on those days through AmazonSmile on their desktop and the app. AmazonSmile must be on and the Alzheimer's Association selected; 0.5% of eligible purchases will be donated to the Association.

More Resources:

Stages of Alzheimer's

Behaviors

Coping Strategies

Care Training


My Preferences:
Unsubscribe To stop receiving our weekly e-newsletter, simply unsubscribe.		Subscribe Was this e-newsletter forwarded to you? Subscribe to get it weekly.